Kronos Bio, Inc. (Nasdaq:KRON)
Health Care/Life Sciences • Biotechnology
CIK 1741830
Company
Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic transcription factors, small cell, prostate cancer, and MYC-driven cancers. The company was founded by Angela Koehler and Joshua Kazam in 2017 and is headquartered in Cambridge, MA.
Address
1300 So. El Camino Real
Suite 300
San Mateo, California 94402
1300 So. El Camino Real
Suite 300
San Mateo, California 94402
Employees
63
63
Stock Info
Close
$0.9500
$0.9500
Day Range
0.9442 - 0.9851
0.9442 - 0.9851
52 Week Range
0.6900 - 1.6000
0.6900 - 1.6000
Average volume
292.93K
292.93K
Short Interest
917.99K (02/14/25)
917.99K (02/14/25)
% of Float Shorted
2.36%
2.36%
Market Cap
$57.32M
$57.32M
Revenue
$6.29M
$6.29M
Net Income
-$112.67M
-$112.67M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Director Joshua A. Kazam |
Director David M. Tanen |
Director Norbert W. Bischofberger |
Chairman Arie S. Belldegrun |
Independent Director Katherine Vega Stultz |
Independent Director Roshawn A. Blunt |
Independent Director Elena H. Ridloff |
Independent Director Tai Yin Yang |
Independent Director Roger D. Dansey |
SEC filings
Date | Form | Event |
---|---|---|
27 Nov, 2024 | 8-K | |
14 Nov, 2024 | EFFECT | |
14 Nov, 2024 | SC 13G/A | |
13 Nov, 2024 | 10-Q | |
13 Nov, 2024 | 8-K | |
12 Nov, 2024 | UPLOAD | |
12 Nov, 2024 | CORRESP | |
7 Nov, 2024 | 8-K | |
7 Nov, 2024 | S-3 | |
15 Oct, 2024 | 4 | |
15 Oct, 2024 | 4 | |
8 Aug, 2024 | 10-Q | |
8 Aug, 2024 | 8-K | |
2 Jul, 2024 | SC 13D/A | |
1 Jul, 2024 | 4 | |
27 Jun, 2024 | 8-K | |
26 Jun, 2024 | 4 | |
26 Jun, 2024 | 4 | |
26 Jun, 2024 | 4 | |
26 Jun, 2024 | 4 | |
26 Jun, 2024 | 4 | |
26 Jun, 2024 | 4 | |
26 Jun, 2024 | 4 | |
26 Jun, 2024 | 4 | |
12 Jun, 2024 | SC 13D/A | |
12 Jun, 2024 | 4 | |
4 Jun, 2024 | 3 | |
4 Jun, 2024 | 4 | |
21 May, 2024 | 8-K | |
21 May, 2024 | DEFA14A | |
9 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
29 Apr, 2024 | ARS | |
29 Apr, 2024 | DEFA14A | |
29 Apr, 2024 | DEF 14A | |
21 Mar, 2024 | S-8 | |
21 Mar, 2024 | 8-K | |
21 Mar, 2024 | 10-K | |
7 Mar, 2024 | 8-K | |
5 Mar, 2024 | 8-K | |
23 Feb, 2024 | 4 | |
23 Feb, 2024 | 4 | |
23 Feb, 2024 | 3 | |
23 Feb, 2024 | 3 | |
23 Feb, 2024 | 3 | |
23 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
25 Jan, 2024 | 8-K | |
5 Jan, 2024 | 4 | |
5 Jan, 2024 | 4 | |
5 Jan, 2024 | 4 | |
19 Dec, 2023 | 8-K | |
13 Dec, 2023 | 4 | |
13 Dec, 2023 | 4 | |
27 Nov, 2023 | SC 13D | |
17 Nov, 2023 | 4 | |
13 Nov, 2023 | 8-K | |
13 Nov, 2023 | 10-Q | |
2 Nov, 2023 | 8-K | |
5 Oct, 2023 | 8-K | |
18 Sep, 2023 | 8-K | |
18 Sep, 2023 | 3 | |
17 Aug, 2023 | 8-K | |
8 Aug, 2023 | 10-Q | |
8 Aug, 2023 | 8-K | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | SC 13G/A | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 8-K | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
30 May, 2023 | 8-K/A | |
30 May, 2023 | 8-K/A | |
10 May, 2023 | 8-K | |
10 May, 2023 | 10-Q | |
27 Apr, 2023 | ARS | |
27 Apr, 2023 | DEFA14A | |
27 Apr, 2023 | DEF 14A | |
24 Apr, 2023 | 8-K | |
24 Apr, 2023 | 4 | |
24 Apr, 2023 | 3 | |
11 Apr, 2023 | 3 | |
11 Apr, 2023 | 8-K | |
11 Apr, 2023 | 4 | |
27 Mar, 2023 | 8-K/A | |
27 Mar, 2023 | 8-K | |
15 Mar, 2023 | 10-K | |
15 Mar, 2023 | S-8 | |
15 Mar, 2023 | 8-K | |
24 Feb, 2023 | 4 | |
24 Feb, 2023 | 4 | |
24 Feb, 2023 | 4 | |
17 Feb, 2023 | 4 | |
17 Feb, 2023 | 4 | |
17 Feb, 2023 | 4 | |
17 Feb, 2023 | 4 | |
17 Feb, 2023 | 4 | |
13 Feb, 2023 | SC 13G/A | |
13 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
1 Feb, 2023 | SC 13G/A | |
26 Jan, 2023 | 8-K | CEO Change |
9 Jan, 2023 | 8-K | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | 4 | |
8 Nov, 2022 | 10-Q | |
8 Nov, 2022 | 8-K | |
9 Sep, 2022 | 10-K/A | |
9 Sep, 2022 | 10-Q/A | |
9 Sep, 2022 | 10-Q/A | |
4 Aug, 2022 | 10-Q | |
4 Aug, 2022 | 8-K | |
27 Jul, 2022 | 4 | |
27 Jul, 2022 | 4 | |
27 Jul, 2022 | 4 | |
27 Jul, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
23 Jun, 2022 | 8-K | |
19 May, 2022 | 4 | |
4 May, 2022 | 10-Q | |
4 May, 2022 | 8-K | |
27 Apr, 2022 | DEFA14A | |
27 Apr, 2022 | DEF 14A | |
21 Apr, 2022 | 8-K | |
9 Mar, 2022 | 4 | |
1 Mar, 2022 | EFFECT | |
25 Feb, 2022 | POS AM | |
24 Feb, 2022 | 8-K | |
24 Feb, 2022 | S-8 | |
24 Feb, 2022 | POSASR | |
24 Feb, 2022 | 10-K | |
17 Feb, 2022 | SC 13G/A | |
17 Feb, 2022 | SC 13G/A | |
17 Feb, 2022 | 4 | |
17 Feb, 2022 | 4 | |
17 Feb, 2022 | 4 | |
17 Feb, 2022 | 4 | |
17 Feb, 2022 | 4 | |
11 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G | |
10 Feb, 2022 | SC 13G | |
4 Feb, 2022 | SC 13G | |
15 Dec, 2021 | 4 | |
15 Dec, 2021 | 4 | |
8 Dec, 2021 | 4 | |
6 Dec, 2021 | 8-K | |
2 Dec, 2021 | 4 | |
29 Nov, 2021 | 8-K | |
15 Nov, 2021 | 3 | |
15 Nov, 2021 | 4 | |
12 Nov, 2021 | 8-K/A | |
12 Nov, 2021 | 8-K | |
9 Nov, 2021 | S-3ASR | |
9 Nov, 2021 | 8-K | |
9 Nov, 2021 | 10-Q | |
4 Oct, 2021 | 4 | |
9 Sep, 2021 | 4 | |
24 Aug, 2021 | 4 | |
12 Aug, 2021 | 8-K | |
12 Aug, 2021 | 10-Q | |
3 Aug, 2021 | 4 | |
25 Jun, 2021 | 8-K/A | |
24 Jun, 2021 | 8-K | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
1 Jun, 2021 | 4 | |
25 May, 2021 | 8-K | |
11 May, 2021 | 8-K | |
11 May, 2021 | 10-Q | |
4 May, 2021 | SC 13G | |
28 Apr, 2021 | 3/A | |
27 Apr, 2021 | DEFA14A | |
27 Apr, 2021 | DEF 14A | |
20 Apr, 2021 | 4 | |
15 Apr, 2021 | 4 | |
12 Apr, 2021 | 4 | |
26 Mar, 2021 | 8-K | |
26 Mar, 2021 | 3 | |
26 Mar, 2021 | 4 | |
23 Mar, 2021 | 10-K | |
23 Mar, 2021 | 8-K | |
23 Mar, 2021 | S-8 | |
4 Mar, 2021 | 8-K | |
16 Feb, 2021 | SC 13G | |
12 Feb, 2021 | SC 13G | |
10 Feb, 2021 | 8-K | |
27 Jan, 2021 | 4 | |
27 Jan, 2021 | 3 | |
26 Jan, 2021 | 8-K |
Last update:2025-03-06 12:38:13.285973
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.